<DOC>
	<DOCNO>NCT00296478</DOCNO>
	<brief_summary>This multicenter , randomize , open-label study perform approximately 990 healthy female undergo IVF . Each study center follow study center standard practice IVF unless otherwise note protocol . The study center provide medication regulation , stimulation ovulation induction . The subject randomize study medication day oocyte retrieval day follow continue treatment 10 week . The subject confirm pregnancy require return clinic several time course 10 week treatment period serum pregnancy test transvaginal ultrasound monitor pregnancy .</brief_summary>
	<brief_title>Multi-Center , Randomized , Open-Label , Parallel Group Study Vaginal Micronized Progesterone Tablet ( Endometrin® ) Compared Crinone 8 % Vaginal Gel Female Patients Undergoing In-Vitro Fertilization ( IVF )</brief_title>
	<detailed_description>This multicenter , randomize , open-label study perform approximately 990 healthy female undergo IVF . Each study center follow study center standard practice IVF unless otherwise note protocol . The study center provide medication regulation , stimulation ovulation induction . The subject randomize study medication day oocyte retrieval day follow continue treatment 10 week . The subject confirm pregnancy require return clinic several time course 10 week treatment period serum pregnancy test transvaginal ultrasound monitor pregnancy .</detailed_description>
	<mesh_term>Progesterone</mesh_term>
	<criteria>Inclusion Criteria 1 . Premenopausal females age 18 42 year Nonsmokers . For female past smoker , must stop tobacco usage least 3 month prior baseline visit . 2 . Early follicular phase ( day 24 ) FSH ( follicle stimulate hormone ) less equal 15 IU/L Estradiol within normal limit 3 . LH ( luteinizing hormone ) , PRL ( prolactin ) , T ( testosterone ) , DHEAS ( dehydroepiandrosterone sulfate ) TSH ( thyroidstimulating hormone ) , within normal limit clinical laboratory , consider clinically significant investigator within 6 month prior screen . 4 . Negative serum hepatitis B surface antigen , hepatitis C antibody , HIV antibody , rapid plasma reagin test within 3 month prior screen 5 . Seropositive rubella varicella ABO group Rho ( D ) type prior screen 6 . Documented history infertility ( eg , unable conceive least one year 6 month woman ≥38 year age bilateral tubal occlusion absence ) . 7 . Male partner recent ( within 6 month prior screen ) semen analysis show normalcy adequate IVF standard WHO and/or Kruger criterion . Donor sperm may use , indicate , provide meet standard WHO criteria . 8 . Normal Transvaginal ultrasound screening ( within 14 day screen ) presence least ovary without evidence clinically significant abnormality consistent finding adequate ART respect uterus adnexa ( hydrosalpinx clinically relevant uterine fibroid ) . 9 . At least one cycle fertility medication prior screen . 10 . Hysterosalpingography , hysteroscopy , sonohysterogram document normal uterine cavity . 11 . Negative pregnancy test day pituitary regulation ( prior administration GnRH agonist ) . 12 . Signed informed consent . Exclusion Criteria 1 . Requires Donor oocyte embryo recipient ; gestational surrogate carrier 2 . Undergoing blastomer biopsy experimental ART procedures 3 . Inadequate number oocyte define few 3 oocyte retrieve study cycle 4 . Presence clinically relevant systemic disease ( eg , insulindependent diabetes mellitus ) . 5 . Surgical medical condition judgment Investigator Sponsor may interfere absorption , distribution , metabolism , excretion drug use . 6 . Subjects body mass index ( BMI ) great 34 time Screening . 7 . Previous IVF ART failure due relate either sperm/fertilization problem result unsuccessful fertilization ART poor response gonadotropin . Poor response define development le 2 mature follicle history 2 previous cycle cancellation prior oocyte retrieval due poor response . 8 . Presence abnormal uterine bleeding undetermined origin . 9 . Current recent substance abuse , include alcohol tobacco . ( Note : Patients stop tobacco usage least 3 month prior screen visit would allow ) . 10 . History chemotherapy ( except gestational condition ) radiotherapy . 11 . Currently breast feeding , pregnant contraindication pregnancy . 12 . Refusal inability comply requirement Protocol reason , include schedule clinic visit laboratory test . 13 . For male partner , obvious leukospermia ( &gt; 2 million WBC/mL ) sign infection semen sample within past 2 month pituitary regulation ; either condition exists , male treat antibiotic retested prior partner 's pituitary regulation . 14 . Documented intolerance allergy medication use include study medication . 15 . Participation experimental drug study within 60 day prior Screening . 16 . Use following medication pretreatment treatment phase : hormonal drug product ( use oral contraceptive regulation allow ) , progesterone cream , hydrocortisone steroid drug product , fertility modifier insulin sensitizer . 17 . History recurrent pregnancy loss define 3 spontaneous miscarriage</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>42 Years</maximum_age>
	<verification_date>May 2011</verification_date>
</DOC>